GAPVAC Phase I Trial in Newly Diagnosed Glioblastoma Patients

NCT02149225 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioblastoma

Interventions

DRUG: APVAC1 vaccine plus Poly-ICLC and GM-CSF
DRUG: APVAC2 vaccine plus Poly-ICLC and GM-CSF

Sponsor

Immatics Biotechnologies GmbH

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]